34 results
8-K
EX-3.2
AMBS
Amarantus Bioscience Holdings, Inc.
28 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.3
AMBS
Amarantus Bioscience Holdings, Inc.
28 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
AMBS
Amarantus Bioscience Holdings, Inc.
28 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
AMBS
Amarantus Bioscience Holdings, Inc.
21 Apr 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.2
AMBS
Amarantus Bioscience Holdings, Inc.
21 Apr 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
k6i8ww
4 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.2
oef2ek6r 16wroav
24 Feb 16
Amarantus Announces $3M Capital Infusion
12:00am
8-K
EX-3.1
jy9s99p20cv8l290le
24 Feb 16
Amarantus Announces $3M Capital Infusion
12:00am
8-K
EX-3.1
2ud1cop61zq enb
1 Oct 15
Amarantus Closes $5.5 Million Capital Infusion through the Issuance of a Combination of Preferred Stock and Secured Debt Convertible
12:00am
8-K
EX-3.1
jme aj6bnj6g18
15 Jul 15
Amarantus to Commence Trading on the OTCQX Marketplace under Existing Ticker Symbol AMBS
12:00am
8-K
EX-3.1
2mv1tv rp2tde
15 Jul 15
Amarantus to Commence Trading on the OTCQX Marketplace under Existing Ticker Symbol AMBS
12:00am
8-K
EX-3.1
c5esab8x7 oqhyfx
21 May 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
y81j42jugd5i58lhn2q
28 Apr 15
Amarantus Closes $5 Million Preferred Stock Financing
12:00am
8-K
EX-3.1
10muqai8
3 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
s13f5w s8f4stx
14 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
ogshnx17
24 Dec 14
Amarantus Announces Second Closing of Series E Preferred Financing
12:00am
8-K
EX-3.1
90xmk7
14 Nov 14
Amarantus Reports Third Quarter 2014 Financial Results and Enters Into Strategic Convertible Preferred Financing
12:00am
8-K
EX-3.1
qhri1t8mh7d48cz
10 Oct 14
Amarantus Investigator Presents Positive MANF Animal Data in Central Retinal Vein Occlusion and Glaucoma at the Targeting Ocular Disorders Conference
12:00am
8-K
EX-3.1
9bh0u0m9uodl4h9apta
11 Apr 13
Amendments to Articles of Incorporation or Bylaws
12:00am